1.Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Ready availability of radiopharmaceuticals
4.1.2 Increased awareness about the potential benefits of targeted alpha therapy
4.1.3 Increasing incidences of cardiac & cancer ailments
4.2 Restraints
4.2.1 Reimbursement issues
4.2.2 Stringent regulatory framework
4.2.3 Need for high capital investment
4.2.4 Shorter half-life of radiopharmaceuticals
4.3 Opportunities
4.3.1 Emerging Technologies
4.3.2 Emerging Markets
4.4 Challenges
4.4.1 High Manufacturing Costs
4.4.2 Low awareness
5. The Middle East & Africa Alpha Emitters Market - By Drugs
5.1 Terbium (Tb-149)
5.2 Astatine (At-211)
5.3 Bismuth (Bi-212)
5.4 Actinium (Ac-225)
5.5 Radium (Ra-223)
5.6 Lead (Pb-212)
5.7 Bismuth (Bi -213)
5.8 Others
6. The Middle East & Africa Alpha Emitters Market - By Medical Application
6.1 Glioma
6.2 Melanoma
6.3 Pancreatic Cancer
6.4 Ovarian Cancer
6.5 Thyroid
6.6 Bone Metastasis
6.7 Lymphoma
6.8 Endocrine Tumors
6.9 Others
7. The Middle East & Africa Alpha Emitters Market - By Country
7.1.Introduction
7.2.The Middle East
7.3.Africa
8 Company Profiles
8.1 Bayer Healthcare
8.2 Actinium Pharmaceuticals
8.3 NTP Radioisotopes
8.4 Siemens Healthcare
8.5 Triad Isotopes
8.6 Lantheus Medical Imaging
8.7 IBA Group
8.8 AlphaTau
8.9 Cardinal Health, Inc.
8.10 Nordion, Inc.
8.11 GE Healthcare
8.12 Mallinckrodt PLC
8.13 Plexus NSD
9. The Middle East & Africa Alpha Emitters Market - Competitive Landscape
9.1 Market Share Analysis
9.2 Strategies Adopted by top companies
9.3 Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1 Insights of Industry Experts
10.2 Investment Opportunities
10.3 Analyst Opinion
11. Appendix
11.1 List of Tables
11.2 List of Figures
